Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Programs of Neurosciences and Weill Graduate School of Medical Sciences of Cornell University, New York, NY, USA.
Mol Psychiatry. 2022 Oct;27(10):4264-4273. doi: 10.1038/s41380-022-01676-7. Epub 2022 Jun 28.
Hypoxic-ischemic injury has been linked with increased risk for developing Alzheimer's disease (AD). The underlying mechanism of this association is poorly understood. Here, we report distinct roles for hypoxia-inducible factor-1α (Hif-1α) in the regulation of BACE1 and γ-secretase activity, two proteases involved in the production of amyloid-beta (Aβ). We have demonstrated that Hif-1α upregulates both BACE1 and γ-secretase activity for Aβ production in brain hypoxia-induced either by cerebral hypoperfusion or breathing 10% O. Hif-1α binds to γ-secretase, which elevates the amount of active γ-secretase complex without affecting the level of individual subunits in hypoxic-ischemic mouse brains. Additionally, the expression of full length Hif-1α increases BACE1 and γ-secretase activity in primary neuronal culture, whereas a transcriptionally incompetent Hif-1α variant only activates γ-secretase. These findings indicate that Hif-1α transcriptionally upregulates BACE1 and nontranscriptionally activates γ-secretase for Aβ production in hypoxic-ischemic conditions. Consequently, Hif-1α-mediated Aβ production may be an adaptive response to hypoxic-ischemic injury, subsequently leading to increased risk for AD. Preventing the interaction of Hif-1α with γ-secretase may therefore be a promising therapeutic strategy for AD treatment.
缺氧缺血性损伤与阿尔茨海默病(AD)发病风险增加有关。这种关联的潜在机制尚不清楚。在这里,我们报告了缺氧诱导因子-1α(Hif-1α)在调节 BACE1 和 γ-分泌酶活性方面的独特作用,这两种蛋白酶参与了淀粉样蛋白-β(Aβ)的产生。我们已经证明,在脑缺氧诱导的情况下,无论是由脑灌注不足还是呼吸 10% O2 引起的,Hif-1α都可以上调 BACE1 和 γ-分泌酶活性,从而产生 Aβ。Hif-1α与 γ-分泌酶结合,增加了活性 γ-分泌酶复合物的数量,而不影响缺氧缺血性小鼠脑中单个亚基的水平。此外,全长 Hif-1α在原代神经元培养物中增加 BACE1 和 γ-分泌酶活性,而转录无功能的 Hif-1α变体仅激活 γ-分泌酶。这些发现表明,Hif-1α在转录上上调 BACE1 并在缺氧缺血条件下非转录激活 γ-分泌酶以产生 Aβ。因此,Hif-1α介导的 Aβ产生可能是对缺氧缺血性损伤的适应性反应,随后导致 AD 发病风险增加。因此,阻止 Hif-1α与 γ-分泌酶的相互作用可能是 AD 治疗的一种有前途的治疗策略。